![David Dornan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 917 $ in data 30/06/2025
David Dornan currently works at Whitehawk Therapeutics, Inc., as Chief Scientific Officer from 2025.
Dr. Dornan also formerly worked at Gilead Sciences, Inc., as Director & Head-Oncology Research from 2012 to 2017, Bolt Biotherapeutics, Inc., as Senior Vice President-Research & Manufacturing, and Elevation Oncology, Inc., as Chief Scientific Officer from 2022 to 2025.
Dr. Dornan received his doctorate degree from the University Of Dundee and undergraduate degree from the University of Strathclyde.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2025 | 5.223 ( 0,01% ) | 1 917 $ | 30/06/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 18/02/2025 |
| Società | Posizione | Fine |
|---|---|---|
| ELEN ONCO | Direttore Tecnico/Scientifico/R&S | 17/02/2025 |
| BOLT BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/03/2022 |
| GILEAD SCIENCES, INC. | Direttore/Membro del Consiglio | 01/11/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Elevation Oncology, Inc.
 Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
